Most Read News

On approval, the firm will allot up to 3,000 NCDs of face value ₹10 lakh each.

Revenue during Q4FY25 rose by 4.4% at ₹1,530.6 crore compared with ₹1,466.5 crore witnessed during Q4FY24.

Third-party cargo represented 49% of total, up from 40% in FY24, the result of greater reliance on non-captive business.

The medication is also prescribed to lower the risk of another heart attack in individuals with a past history of myocardial infarction and hyperlipidaemia

EBITDA margins have increased considerably, at 26.2% in Q4 FY25, compared to 15.6% in the corresponding quarter of last year

EBITDA margin also rose to 32.2%, compared to 30.9% last year corresponding quarter

Operating margins were healthy and steady at 30.54%, compared to 30% in the same quarter last year.

This regulatory sanction is under the Payment and Settlement Systems Act, 2007, applicable to digital transaction platforms and payment service providers in India.

EBITDA were ₹559.6 crore for the quarter ended March 2025, down 10.7% from ₹626.6 crore in the same quarter a year ago.

EBITDA went down 6.3% YoY to ₹231.3 crore in Q4FY25 from ₹246.9 crore for the same quarter last year